Oncolytics Biotech Inc shares T.ONC are trading unchanged at $0.74.

It is indicated for patients with a susceptible IDH1 mutation, which is identified through an FDA-approved test. Currently, ...

The Digital Pathology Market is expected to witness a growth rate of ~10.5% by 2029. The key factors driving the market are ...